MedPath

SPECIALISED THERAPEUTICS PM PTY LTD

🇦🇺Australia
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

2

TGA:2

Drug Approvals

QINLOCK ripretinib 50 mg tablet bottle (327899)

Product Name
QINLOCK ripretinib 50 mg tablet bottle
Approval Date
Jul 13, 2020
TGA

NERLYNX neratinib (as maleate) 40 mg film coated tablets (301129)

Product Name
NERLYNX neratinib (as maleate) 40 mg film coated tablets
Approval Date
Mar 15, 2019
TGA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.